Spots Global Cancer Trial Database for gnrh antagonist
Every month we try and update this database with for gnrh antagonist cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Sub-therapeutic GnRH- Antagonist Treatment to Rectify LH Pulsatility in Lean Women With PCOS. | NCT05751252 | Polycystic Ovar... | Ganirelix Ganirelix | 18 Years - 35 Years | University Hospital, Lille | |
| Comparison Between GnRH Agonist and GnRH Antagonist Protocols of Ovarian Stimulation in PCOS Patients | NCT00417144 | Polycystic Ovar... Ovarian Hyperst... | Arvekap 0.1mg (... Ganirelix 0.25m... | 18 Years - 50 Years | Eugonia | |
| A Study to Explore Correlation Between Symptoms and Signs of Polycystic Ovarian Syndrome (PCOS) and Risk of Over-response to Ovarian Stimulation | NCT02607293 | Polycystic Ovar... | Gonal-f® Long GnRH agoni... GnRH antagonist | 20 Years - 35 Years | Merck KGaA, Darmstadt, Germany | |
| Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients. | NCT04727671 | In Vitro Fertil... Intracytoplasmi... Infertility Polycystic Ovar... | Triptorelin ace... Cetrorelix recombinant-FSH... Human Chorionic... | 18 Years - 39 Years | Damascus University | |
| Trial Comparing Irradiation Plus Long Term Adjuvant Androgen Deprivation With GnRH Antagonist Versus GnRH Agonist Plus Flare Protection in Patients With Very High Risk Localized or Locally Advanced Prostate Cancer | NCT02799706 | Prostate Cancer | Degarelix approved GnRH a... Radiotherapy | 18 Years - 80 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Trial Comparing Irradiation Plus Long Term Adjuvant Androgen Deprivation With GnRH Antagonist Versus GnRH Agonist Plus Flare Protection in Patients With Very High Risk Localized or Locally Advanced Prostate Cancer | NCT02799706 | Prostate Cancer | Degarelix approved GnRH a... Radiotherapy | 18 Years - 80 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Phase IV Study to Evaluate Bone Mineral Density in No-bone Metastatic Prostate Cancer Treated With Degarelix | NCT03202381 | Prostate Cancer | Degarelix | 18 Years - | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | |
| Long Acting GnRH Antagonist in PCOS Women Undergoing IVF | NCT02084940 | Polycystic Ovar... Ovarian Hyperst... Invitro Fertili... | GnRH antagonist... | 23 Years - 37 Years | Bioroma | |
| Phase IV Study to Evaluate Bone Mineral Density in No-bone Metastatic Prostate Cancer Treated With Degarelix | NCT03202381 | Prostate Cancer | Degarelix | 18 Years - | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | |
| GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients | NCT06379113 | Endometrial Neo... Atypical Endome... Progesterone Re... Obesity | GnRH antagonist Letrozole 2.5mg | 18 Years - 45 Years | Fudan University | |
| Comparison of the Euploid Rate of Blastocyst Between PPOS and GnRH Antagonist Protocol in Women With PCOS Undergoing PGT-A | NCT05326087 | Preimplantation... Progestin-prime... Polycystic Ovar... GnRH Antagonist | GnRH antagonist MPA | 20 Years - 37 Years | ShangHai Ji Ai Genetics & IVF Institute | |
| Comparison Between GnRH Agonist and GnRH Antagonist Protocols of Ovarian Stimulation in PCOS Patients | NCT00417144 | Polycystic Ovar... Ovarian Hyperst... | Arvekap 0.1mg (... Ganirelix 0.25m... | 18 Years - 50 Years | Eugonia | |
| A Study to Explore Correlation Between Symptoms and Signs of Polycystic Ovarian Syndrome (PCOS) and Risk of Over-response to Ovarian Stimulation | NCT02607293 | Polycystic Ovar... | Gonal-f® Long GnRH agoni... GnRH antagonist | 20 Years - 35 Years | Merck KGaA, Darmstadt, Germany | |
| An Oral GnRH Antagonist to Treat Mild Autonomous Cortisol Excess (MACE) Due to Adrenal Adenomas in Postmenopausal Women | NCT05038878 | Mild Autonomous... | Elagolix | - | Icahn School of Medicine at Mount Sinai | |
| Long Acting GnRH Antagonist in PCOS Women Undergoing IVF | NCT02084940 | Polycystic Ovar... Ovarian Hyperst... Invitro Fertili... | GnRH antagonist... | 23 Years - 37 Years | Bioroma | |
| Polycystic Ovary Syndrome (PCOS) and In Vitro Fertilization (IVF): A Comparison Between Standard Long Protocol Versus an Antagonist Protocol Starting on Day 1 | NCT00883766 | Polycystic Ovar... In Vitro Fertil... | Controlled ovar... Controlled ovar... | 18 Years - 37 Years | Institut Universitari Dexeus | |
| Comparison of the Euploid Rate of Blastocyst Between PPOS and GnRH Antagonist Protocol in Women With PCOS Undergoing PGT-A | NCT05326087 | Preimplantation... Progestin-prime... Polycystic Ovar... GnRH Antagonist | GnRH antagonist MPA | 20 Years - 37 Years | ShangHai Ji Ai Genetics & IVF Institute | |
| The Effect of ADT on PSMA-PET. | NCT03313726 | Prostate Cancer | GnRH antagonist GnRH antagonist | 40 Years - 85 Years | Turku University Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
